Biologics Forum & Networking Reception:

The Rapid Evolution of BioManufacturing and
the New Supplier Reality


Wednesday, March 17, 2010
1:30 - 4:15 pm, Hilton Room
Waldorf-Astoria Hotel, NYC

Networking Reception:
4:15 - 5:30 pm, private dining area of Peacock Alley

Member: $99; Non-Member: $199
(includes education program & networking reception)


Program Description:

Biologics are gaining a growing share of the commercially approved therapeutics and therefore pharmaceutical companies are increasing their R&D and/or manufacturing capacity investments in this area. However, the complex manufacturing processes and the requirement for even more complex analytical characterization (relative to small molecules), requires flawless execution across the entire value chain, from sourcing to manufacturing and distribution, to ensure consistent product quality.

Leading manufacturers will discuss how to design and implement a successful supplier management program to ensure effective biologic manufacturing. They will provide their insight on how economic forces, the changing regulatory landscape and advances in cell-line productivity and disposable technology are driving a rapid evolution of biologics manufacturing and what suppliers need to do to adapt to this new reality.

Suppliers will discuss their current strategies to deliver increased flexibility, improved process economics and reduced time-to-market to support this burgeoning segment of the market. A question and answer session will follow the presentation.

Why should you attend this forum? 

    • This program will be very informative for established biologics
       manufacturerers, as well as companies considering entry into
       biologics development or manufacturing. 
    • This program will bring out the subtleties and nuances of
       managing the complex supply chain of raw materials used in
       biologics manufacturing. 
    • Participants will hear the key trends in biomanufacturing
       and learn how their organizations – be it a biologic
       manufacturer, a contract manufacturer or a supplier of
       materials and components – need to adapt to
       remain competitive.

The networking reception following the event will allow participants to interact and develop relationships with a variety of industry leaders.

Speakers:

Girish J. Pendse, Ph.D., Assoc. Vice President, PD Cell Culture
ImClone Systems,
a wholly owned subsidiary of Eli Lilly & Company 

Nigel Darby, Vice President, BioTechnologies,
GE Healthcare Life Sciences

Jim Skrine, Executive Director and Site Head of Quality 
Amgen Inc. 

Karen King, President
DSM, Biologics Division

Michael Howaldt, PhD, Vice President Biotech Operations
Biopharma Business Unit, Boehringer Ingelheim

Moderated by Marc Lampron, Senior Director - Procurement, Genentech